Skip to main content
letter
. 2021 Jan 27;93(5):2583–2584. doi: 10.1002/jmv.26800

Figure 1.

Figure 1

 Clinical performance of the Centaur XP anti‐SARS‐CoV‐2 immunoassay: kinetics of the antibody response in COVID patients relative to time since positive RT‐PCR/or COVID‐antigen (A) and to time since symptom onset (B) as compared with prepandemic controls. RT‐PCR, reverse transcription polymerase chain reaction; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2